# Run review: `retinopathy-scope-20261101-1`

**Run date:** 1 November 2026. **Model:** local `qwen3:8b`.

The guarded seven-stage drill completed with 31 decisions and one configured gap record. Its hash chain verified. The retrospective evidence audit found 13 decisions without citation and one citation review flag. The decisions omitted the earlier DHA standard citations for the step 2 DHA and step 6 EDE actions. A step 7 MoHAP decision still cited the standard's bibliography pages 21–22 for regulatory coordination; those pages do not establish that authority.

After this run, the known bibliography pages were excluded from future retrieval and flagged in citation triage, while remaining in the archived pack so old run citations remain resolvable. The ten-question exact-passage seed still returns 9/10 within top six. The exclusion has focused test coverage but has not yet been evaluated in a new full drill.

The run is a simulation artifact, not proof of legal correctness. The synthetic product classification, authority for the configured liaison route, and the gap hypothesis remain unresolved.

Verification: `make verify-log RUN=retinopathy-scope-20261101-1` passed; `.venv/bin/python -m pytest -q` reported 17 passed; `make audit-evidence RUN=retinopathy-scope-20261101-1` produced the screening counts above.
